Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy

Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy

Abstract Background Several studies have reported the incidence of interstitial pneumonia (IP) among patients with non-Hodgkin lymphoma (NHL) that are undergoing combination chemotherapy plus rituximab; however, the effective prophylactic treatment for IP remains unclear. This study aims to explore...

Full description

Bibliographic Details
Main Authors: Cong Li, Fangxiao Lu, Tao Lei, Haifeng Yu, Xi Chen, Shuailing Peng, Shuiyun Han, Haiyan Yang
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Cancer
Subjects:
B-cell lymphoma
Chemotherapy
Interstitial pneumonia
TMP-SMX
Rituximab
Online Access:http://link.springer.com/article/10.1186/s12885-020-07254-w

Internet

http://link.springer.com/article/10.1186/s12885-020-07254-w

Similar Items